@article{bousmah:inserm-04312474,
  TITLE = {{Improvements in Patient-Reported Outcomes Following Initiation of Dolutegravir-Based or Low-Dose Efavirenz-Based First-Line Antiretroviral Therapy: A Four-Year Longitudinal Analysis in Cameroon (NAMSAL ANRS 12313 Trial)}},
  AUTHOR = {Bousmah, Marw{\^a}n-Al-Qays and Protopopescu, Camelia and Mpoudi-Etame, Mireille and Omgba Bassega, Pierrette and Maradan, Gwena{\"e}lle and Olinga, Justin and Varloteaux, Marie and Tovar-Sanchez, Tamara and Delaporte, {\'E}ric and Kouanfack, Charles and Boyer, Sylvie},
  URL = {https://inserm.hal.science/inserm-04312474},
  JOURNAL = {{Journal of Acquired Immune Deficiency Syndromes - JAIDS}},
  PUBLISHER = {{Lippincott, Williams \& Wilkins}},
  VOLUME = {94},
  NUMBER = {3},
  PAGES = {262-272},
  YEAR = {2023},
  MONTH = Nov,
  DOI = {10.1097/QAI.0000000000003273},
  HAL_ID = {inserm-04312474},
  HAL_VERSION = {v1},
}